Try our mobile app
ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings” or “Company”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Company”) NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(b) OF THE JSE LISTINGS REQUIREMENTS In accordance with section 122(3)(b) of the Companies Act 71 of 2008 (“the Act”) and paragraph 3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that Coronation Asset Management (Pty) Limited has formally notified the Company that it has increased its beneficial interest in the securities of the Company, which it holds on behalf of its clients, to 5.10% of the ordinary share capital of the Company, effective 13 March 2023. Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section 122(3)(a) of the Act. The board of directors accepts responsibility for the information contained in this announcement, and to the best of their knowledge and belief, that information is true, and this announcement does not omit anything likely to affect the importance of the information included. Durban 13 March 2023 Sponsor: Investec Bank Limited
